Career history of Jean-Paul St-Pierre
Former positions of Jean-Paul St-Pierre
| Companies | Position | Start | End |
|---|---|---|---|
Ambrilia Biopharma, Inc.
 Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Director/Board Member | 07/12/2007 | 31/03/2010 |
| Hoechst Marion Roussel Canada, Inc. | Chief Tech/Sci/R&D Officer | - | - |
| Rhône-Poulenc, Inc. | Chief Tech/Sci/R&D Officer | - | - |
Synapse Technologies, Inc.
 Synapse Technologies, Inc. Pharmaceuticals: MajorHealth Technology Synapse Technologies Inc. develops an Alzheimer's diagnostic test and potential blood/brain drug delivery mechanism based on the p97 protein. | President | - | - |
Sandoz Canada, Inc.
 Sandoz Canada, Inc. Pharmaceuticals: MajorHealth Technology Sandoz Canada, Inc. develops, manufactures, and distributes injections and ophthalmic pharmaceutical products for the hospital and retail markets. It offers ampoules, vials ophthalmic solutions, suspensions and ointments, and suppositories. The company was founded in 1973 and is headquartered in Boucherville, Canada. | Chief Tech/Sci/R&D Officer | - | - |
Training of Jean-Paul St-Pierre
| University of Montréal | Doctorate Degree |
Statistics
International
| Canada | 6 |
| United States | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Director/Board Member | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
| Process Industries | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 5 |
|---|---|
Ambrilia Biopharma, Inc.
Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Health Technology |
Sandoz Canada, Inc.
Sandoz Canada, Inc. Pharmaceuticals: MajorHealth Technology Sandoz Canada, Inc. develops, manufactures, and distributes injections and ophthalmic pharmaceutical products for the hospital and retail markets. It offers ampoules, vials ophthalmic solutions, suspensions and ointments, and suppositories. The company was founded in 1973 and is headquartered in Boucherville, Canada. | Health Technology |
Synapse Technologies, Inc.
Synapse Technologies, Inc. Pharmaceuticals: MajorHealth Technology Synapse Technologies Inc. develops an Alzheimer's diagnostic test and potential blood/brain drug delivery mechanism based on the p97 protein. | Health Technology |
| Rhône-Poulenc, Inc. | Process Industries |
| Hoechst Marion Roussel Canada, Inc. |
- Stock Market
- Insiders
- Jean-Paul St-Pierre
- Experience
